Though the mean concentration of serum LRG1 in serous ovarian cancer patients differed between samples in the two data sets, differences in serum preparation and storage may have affected the quantity of LRG1 detected. This evidence concerns the gene LRG1 and ovarian serous adenocarcinoma.